Observers of MEDNAX acquisition have questions; vRad has answers

Dave Pearson | | Radiology Business | Leadership

What is MEDNAX and why did it buy vRad?

For that matter, how is this deal good for vRad’s clients? Will vRad change its name? And should vRad clients continue to contact their current sales and service reps?

These questions and many more are in the air as Florida-based Mednax, a national multispecialty medical group, moves to take ownership of 350-radiologist vRad, the major national telerad outfit based in Minnesota, in a cash transaction valued at $500 million and expected to close quite quickly.

Anticipating the interest, vRad has posted frequently asked questions (FAQs)—with answers—on its website. 

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

President of medical device company resigns over conduct allegations after 7 months in role
Radiology CEO discusses bankruptcy and why he’s optimistic about his company’s second-chance future
Hospitals increasingly funding their own radiology residency positions
Society of Interventional Radiology names new CEO
Frequent AI use may increase radiologists’ risk of burnout
Radiology Business Announces Forty Under 40 Class of 2024

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.